Literature DB >> 19213958

Dynamic protein kinase a activities induced by beta-adrenoceptors dictate signaling propagation for substrate phosphorylation and myocyte contraction.

Dagoberto Soto1, Vania De Arcangelis, Jin Zhang, Yang Xiang.   

Abstract

cAMP/protein kinase (PK)A activation represents a key signaling mechanism for neurohormonal stimulation of diversified physiological processes. Using real-time, fluorescence resonance energy transfer-based imaging of PKA activity in neonatal cardiac myocytes, we report that sustained activation of PKA induced by beta-adrenoceptor (betaAR) dictates signaling propagation for substrate phosphorylation and myocyte contraction. Activation of betaARs in wild-type myocytes induces strong and sustained PKA activities, which are rapidly attenuated on washing away agonist or adding antagonist to the cells. The sustained PKA activities promote signaling propagation to the sarcoplasmic reticulum for phosphorylation of phospholamban and increases in myocyte contraction. Addition of antagonist after betaAR stimulation significantly attenuates PKA phosphorylation of phospholamban and rapidly reduces contraction rate increases. Moreover, stimulation of beta(1)AR subtype induces PKA activities similar to those in wild-type cells. In contrast, stimulation of beta(2)AR subtype induces strong initial activation of PKA similar to those induced by beta(1)AR; however, the activities are rapidly decreased to baseline levels. The transient PKA activities are sufficient for phosphorylation of the overexpressed beta(2)ARs under agonist stimulation, but not phospholamban. Further analysis reveals that phosphodiesterase 4 is the major family that shapes PKA activities under betaAR stimulation. Inhibition of phosphodiesterase 4 extends beta(2)AR-induced PKA activities, promotes PKA phosphorylation of phospholamban, and ultimately enhances myocyte contraction responses. Together, our data have revealed insights into kinetics of PKA activities in signaling propagation under neurohormonal stimulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19213958      PMCID: PMC3075876          DOI: 10.1161/CIRCRESAHA.108.187880

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

1.  G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels.

Authors:  Y Chen-Izu; R P Xiao; L T Izu; H Cheng; M Kuschel; H Spurgeon; E G Lakatta
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling.

Authors:  Y Y Zhou; H Cheng; K Y Bogdanov; C Hohl; R Altschuld; E G Lakatta; R P Xiao
Journal:  Am J Physiol       Date:  1997-09

3.  Myocyte adrenoceptor signaling pathways.

Authors:  Yang Xiang; Brian K Kobilka
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

4.  Beta 2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation.

Authors:  R P Xiao; C Hohl; R Altschuld; L Jones; B Livingston; B Ziman; B Tantini; E G Lakatta
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

5.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor.

Authors:  C A Milano; L F Allen; H A Rockman; P C Dolber; T R McMinn; K R Chien; T D Johnson; R A Bond; R J Lefkowitz
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

6.  Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor.

Authors:  Vania De Arcangelis; Dagoberto Soto; Yang Xiang
Journal:  Mol Pharmacol       Date:  2008-08-14       Impact factor: 4.436

Review 7.  Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

Authors:  Marco Conti; Wito Richter; Celine Mehats; Gabriel Livera; Jy-Young Park; Catherine Jin
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

8.  Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.

Authors:  Stephen J Perry; George S Baillie; Trudy A Kohout; Ian McPhee; Maria M Magiera; Kok Long Ang; William E Miller; Alison J McLean; Marco Conti; Miles D Houslay; Robert J Lefkowitz
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

9.  Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases.

Authors:  Marco Mongillo; Theresa McSorley; Sandrine Evellin; Arvind Sood; Valentina Lissandron; Anna Terrin; Elaine Huston; Annette Hannawacker; Martin J Lohse; Tullio Pozzan; Miles D Houslay; Manuela Zaccolo
Journal:  Circ Res       Date:  2004-06-03       Impact factor: 17.367

10.  beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.

Authors:  George S Baillie; Arvind Sood; Ian McPhee; Irene Gall; Stephen J Perry; Robert J Lefkowitz; Miles D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more
  40 in total

1.  Equilibrium between adenylyl cyclase and phosphodiesterase patterns adrenergic agonist dose-dependent spatiotemporal cAMP/protein kinase A activities in cardiomyocytes.

Authors:  Vania De Arcangelis; Shubai Liu; Dawen Zhang; Dagoberto Soto; Yang K Xiang
Journal:  Mol Pharmacol       Date:  2010-06-07       Impact factor: 4.436

2.  Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons.

Authors:  Dayong Wang; Eunice Y Yuen; Yuan Zhou; Zhen Yan; Yang K Xiang
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

3.  Functional antagonism of β-adrenoceptor subtypes in the catecholamine-induced automatism in rat myocardium.

Authors:  D C Boer; J W M Bassani; R A Bassani
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 4.  Whole-Cell cAMP and PKA Activity are Epiphenomena, Nanodomain Signaling Matters.

Authors:  Donald M Bers; Yang K Xiang; Manuela Zaccolo
Journal:  Physiology (Bethesda)       Date:  2019-07-01

5.  Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels.

Authors:  C Blake Nichols; Charles F Rossow; Manuel F Navedo; Ruth E Westenbroek; William A Catterall; Luis F Santana; G Stanley McKnight
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

Review 6.  Compartmentalization of beta-adrenergic signals in cardiomyocytes.

Authors:  Yang K Xiang
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

7.  Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate.

Authors:  Zachary M Sellers; Vania De Arcangelis; Yang Xiang; Philip M Best
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

8.  MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes.

Authors:  Zachary M Sellers; Anjaparavanda P Naren; Yang Xiang; Philip M Best
Journal:  Eur J Pharmacol       Date:  2012-02-20       Impact factor: 4.432

Review 9.  Compartmentalization of β-adrenergic signals in cardiomyocytes.

Authors:  Qin Fu; Xiongwen Chen; Yang K Xiang
Journal:  Trends Cardiovasc Med       Date:  2013-03-23       Impact factor: 6.677

10.  Higenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway.

Authors:  Mei-ping Wu; Yi-shuai Zhang; Qian-mei Zhou; Jian Xiong; Yao-rong Dong; Chen Yan
Journal:  Pharmacol Res       Date:  2015-12-30       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.